Lates News

Most Hong Kong-listed stocks in the innovative pharmaceutical concept sector continue to strengthen, with Huahao Zhongtian Medicine leading the way with a significant increase of 23.55%, marking its third consecutive day of gains exceeding 120%. Kangfang Biology rose by 5.66%, while shares of Yunding New Bright, Hengrui Medicine, Pharmaron, China Biologic Products, Pharmaron Conde, and Fosun Pharma also followed suit.